Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study

Bibliographic Details
Main Authors:	Rosario Pivonello, Irina Bancos, Richard A. Feelders, Atil Y. Kargi, Janice M. Kerr, Murray B. Gordon, Cary N. Mariash, Massimo Terzolo, Noel Ellison, Andreas G. Moraitis
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-04-01
Series:	Frontiers in Endocrinology
Subjects:	clinical trial cortisol Cushing syndrome glucocorticoid hypercortisolism hyperglycemia
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2022.899616/full

Internet